Comparison Between the Clinical Effect of Percutaneous Kyphoplasty for Osteoporosis Vertebral Compression Fracture Patient with or Without Sarcopenia: A Retrospective Cohort Study
Yujie Peng,Xiaochuan Wu,Xinyu Ma,Dingli Xu,Yang Wang,Dongdong Xia
DOI: https://doi.org/10.2147/IJGM.S423016
IF: 2.145
2023-07-22
International Journal of General Medicine
Abstract:Yujie Peng, 1 Xiaochuan Wu, 1 Xinyu Ma, 2 Dingli Xu, 3 Yang Wang, 4 Dongdong Xia 1 1 Orthopeadic Department, The First Affiliated Hospital of Ningbo University, Ningbo, People's Republic of China; 2 Emergency Department, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, People's Republic of China; 3 Clinical Department, Health Science Center, Ningbo University Zhejiang, Ningbo, People's Republic of China; 4 Orthopeadic Department, Ningbo No.6 Hospital, Ningbo, Zhejiang, People's Republic of China Correspondence: Dongdong Xia, Email Background: Sarcopenia and osteoporosis vertebral compression fractures (OVCF) are common diseases that increase with age. This study aimed to investigate the effects of sarcopenia on OVCF patients after percutaneous kyphoplasty (PKP). Methods: Data of 101 patients who were treated with single-level PKP between January 2021 and March 2022 at Ningbo No.6 Hospital were enrolled. Forty-five OVCF patients with sarcopenia who met our inclusion criteria were included in the Sarcopenia-PKP group (SPKP group), and 56 patients in the Normal-PKP group (NPKP group). All clinical and radiological data were collected from medical records. Baseline characteristics, operation-related parameters (operation time, time to ambulation, hospital stay, surgery segment), clinical outcomes (visual analog score [VAS], Oswestry Disability Index [ODI], Japanese Orthopaedic Association Scores [JOA] of lumber), radiological outcomes (vertebral anterior height rate and local kyphosis angle), Macnab score, and complications were evaluated and compared. Results: There were no significant differences in age, sex, surgical segment preoperative VAS score, ODI, or JOA between the two groups (P > 0.05). The SPKP group had a significantly lower body mass index (BMI), bone mineral density (BMD), and smooth muscle index (SMI) than the NPKP group (P < 0.05). Significantly longer hospital stays and time to ambulation in SPKP group than NPKP group (3.7± 0.8 vs 3.4± 0.5 and 2.0± 0.8 vs 1.6± 0.5, P < 0.05). In SPKP group, significantly better clinical outcomes at 6- and 12-months follow-up were observed in NPKP group than SPKP group (P < 0.05), and NPKP group showed significantly better in vertebral anterior height rates than SPKP group after 6-month follow-up (P < 0.05). Moreover, there were significantly more cases of complications in the SPKP group (P < 0.05). Conclusion: Sarcopenia could reduce the clinical effect of percutaneous kyphoplasty, and furthermore. Related studies are needed to verify the effect of sarcopenia on OVCF patients. Keywords: sarcopenia, percutaneous kyphoplasty, osteoporosis vertebral compression fracture, clinical effect Osteoporotic vertebral compression fracture (OVCF) has a debilitating effect on human health, and its incidence is gradually increasing worldwide. According to Zheng et al, there was a 1.79-fold increase in the incidence of OVCF in patients aged over 50 years in China, rising from 85.21/100,000 in 2013 to 152.13/100,000 person-years in 2017. 1 In a nationwide population-based study of OVCF in South Korea, Choi et al found that the number of OVCF patients increased from 117,361 in 2012 to 139,889 in 2016, with 45% of the OVCF patients being over 70 years of age. 2 Similarly, Cauley et al reported that the prevalence of OVCF was 10.6% in black women and 19.1% in white women aged ≥65 years in the USA. 3 OVCF also poses a huge burden on society. Hopkins et al reported that the average costs of patients treated with percutaneous kyphoplasty (PKP) was US 32,972 in outpatient departments. 4 The degeneration of paravertebral muscles and ligaments in older patients with OVCF can lead to a substantial reduction in anterior vertebral height. This, in turn, may result in spinal kyphosis and even spinal sagittal imbalance. Thus, the primary goals of treatment involve restoring vertebral height and spinal realignment, thereby decreasing the time required for ambulation and providing relief from back pain. 5 Percutaneous kyphoplasty (PKP) is currently one of the most common surgical treatments for OVCF, and many studies have reported that patients who undergo PKP achieve satisfactory pain relief and improvement in spinal function. In a study involving 232 patients (87 with osteoporosis and 81 with osteopenia) with single-segment vertebral compression fractures who underwent PKP, Ge et al reported that all patients achieved significant pain relief and kyphotic angle improvement (P < 0.05). 6 However, previous studies have reported that some patients may experience varying degrees o -Abstract Truncated-
medicine, general & internal